View Older Stories View More Recent Stories
-
Cure® Names Seema Kumar Chief Executive Officer
-
Adaptive Phage Therapeutics Awarded Additional $5 Million from U.S. Defense Health Agency to Support Diabetic Foot Osteomyelitis Clinical Trial
-
Lumos Pharma to Participate in the Cantor Neurology & Psychiatry Conference
-
Lumos Pharma to Participate in the Cantor Neurology & Psychiatry Conference
-
AlivaMab Discovery Services Reappoints Dr. Larry Green as Chief Executive Officer
-
Quartet Health Adds National Clinical Leaders to its Executive Team to Expand the Company's Commitment to Quality Mental Health Care
-
Form 4 Larimar Therapeutics, For: Sep 16 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
-
Moffitt Cancer Center and Deerfield Management Launch Bayfield Therapeutics
-
Larimar Therapeutics Announces Closing of Underwritten Offering and Full Exercise of Option to Purchase Additional Shares
-
Larimar Therapeutics (LRMR) Announces $70 Million Underwritten Offering of Common Stock
-
Larimar Therapeutics Announces $70 Million Underwritten Offering
-
Innervace Secures Up to $40 Million to Advance Novel Regenerative Medicine Platform for Neurological Disorders
-
BIDMC and Deerfield Management Announce Research Collaboration to Accelerate the Creation and Development of Therapeutics
-
Neomorph, Inc. Announces Appointment of Chief Financial Officer
-
Neomorph, Inc. Announces Appointment of Chief Financial Officer
-
SpringWorks Therapeutics (SWTX) Announces $225 Million Private Placement Financing
-
SpringWorks Therapeutics Announces $225 Million Private Placement Financing
-
SpringWorks Therapeutics Announces $225 Million Private Placement Financing
-
Medical Microinstruments Introduces Even Smaller Robotic Instruments to Address Complex Supermicrosurgery
-
Lumos Pharma to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
-
Lumos Pharma to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
-
Lumos Pharma, Inc. (LUMO) Announces $3M Share Buyback
-
Lumos Pharma Announces Share Repurchase Program
-
Lumos Pharma Announces Share Repurchase Program
-
Form 13F-HR DEERFIELD MANAGEMENT For: Jun 30
-
ADC Therapeutics Announces $175 million Senior Secured Term Loan from Owl Rock and Oaktree and Settlement of Existing Senior Secured Convertible Notes
-
Miravo Healthcare™ Announces Second Quarter 2022 Results
-
Vigil Neuroscience (VIGL) Announces $75 Million Private Placement of Common Stock, Warrants
-
Vigil Neuroscience Announces $75 Million Private Placement Financing
-
Vigil Neuroscience Announces $75 Million Private Placement Financing
-
The Oncology Institute, Inc (TOI) Announces $110M Investment by Deerfield Management
-
The Oncology Institute Reports Second Quarter 2022 Financial Results and Reaffirms Full Year 2022 Guidance
-
The Oncology Institute Reports Second Quarter 2022 Financial Results and Reaffirms Full Year 2022 Guidance
-
The Oncology Institute announces $110 million strategic investment by Deerfield Management to accelerate its expansion into new markets
-
The Oncology Institute announces $110 million strategic investment by Deerfield Management to accelerate its expansion into new markets
-
Lumos Pharma Reports Second Quarter 2022 Financial Results and Clinical Development Updates
-
Lumos Pharma Reports Second Quarter 2022 Financial Results and Clinical Development Updates
-
Endologix Receives CE Mark Certification under EU-MDR for AFX®2 Endovascular AAA System
-
Element Science Announces First Patient Save with Jewel Patch Wearable Cardioverter Defibrillator (P-WCD)
-
NYC Healthcare Innovation Campus, Cure®, Fuels Economic Growth
-
Vicinitas Therapeutics Launches With $65 Million in Series A Financing to Advance Precision Medicines to Stabilize Key Proteins to Treat Disease
-
Lumos Pharma to Report Second Quarter 2022 Financial Results and Host Conference Call on August 9, 2022
-
Lumos Pharma to Report Second Quarter 2022 Financial Results and Host Conference Call on August 9, 2022
-
Medical Microinstruments Secures $75M to Advance Robotic Microsurgery
-
Conventus Flower Orthopedics Appoints Bradley Niemann as Chief Executive Officer
-
Humanity Health Announces $6 Million Series A Funding Round
-
Apertura Appoints Gene Therapy Executive Joseph La Barge as Chief Executive Officer
-
Acutus Medical Completes First Closing of Transaction with Medtronic and Debt Refinancing to Fund Strategic Growth Priorities
-
Endologix Reports 12 Month Data from DETOUR 2 Clinical Trial at 2022 Vascular Annual Meeting
-
CobiCure launches to change the course of pediatric healthcare
